PEDIATRICS Vol. 34 No. 4 October 1964, pp. 585
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRADY, R. O.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BRADY, R. O.

Opportunity to Advance Knowledge of Gaucher's Disease

ROSCOE O. BRADY M.D.1

1 Chief, Section on Lipid Chemistry, Laboratory of Neurochemistry, National Institute of Neurological Diseases and Blindness, Bethesda, Md. 20014

We are interested in the metabolic aberrations which occur in patients with sphingolipidoses and in particular in Gaucher's disease.

We have recently synthesized some glucoselabeled cerebroside and have examined the catabolism of this compound in normal rat and human spleen tissues. We have found a very active enzyme which splits this material in these tissues and we are particularly interested in examining spleen tissues from Caucher's patients to try to determine if this particular enzyme is present or absent in tissues from these patients.